Heparine Sodium. Primarily systemic and haematological agent, unspecified
Conditions
Interventions
Intervention 1: Equalize insulin syringes (manufactured by Iran Medical Company) with a 1000-heparin solution (for intervention group) for 1000 heparin units. One heparin injection of 5000 units of th
Treatment - Drugs
Equalize insulin syringes (manufactured by Iran Medical Company) with a 1000-heparin solution (for intervention group) for 1000 heparin units. One heparin injection of 5000 units of the Alborz Drug Co
In the control group, based on the status quo, heparin ampoules of 5,000 units were found to be 0.1ml To insert the insulin syringes used for blood sampling, arterial blood gas was used
Sponsors
Sabzevar University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 70 Years
Inclusion criteria
Inclusion criteria: Entry criteria Inclination to participate in appropriate blood flow to the affected arteries 18 to 70 years of age Patients underwent trauma under mechanical ventilation up to one week Standard for insufficient bleeding in the blood collection site Lesion or surgical shunt (presence of fistula in it Limb) evidence of peripheral vascular disease in the surrounding area of the cochlear region Coagulopathy or anticoagulant treatment with a moderate to high dose of other patients admitted to other parts of the body Active infection in the arterial pathway and any damage to the limbs include: fracture, dislocation, and Death burn or deterioration of the chest trauma section
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Heparin 1000 unit. Timepoint: One day on the first day, the second day, the third day. Method of measurement: Laboratory, arterial blood gas meter.;Sodium. Timepoint: One day on the first day, the second day, the third day. Method of measurement: Laboratory, arterial blood gas meter.;Kalium. Timepoint: One day on the first day, the second day, the third day. Method of measurement: Laboratory, arterial blood gas meter.;Calcium. Timepoint: Onse. Method of measurement: lab Test.;Pao2. Timepoint: One day on the first day, the second day, the third day. Method of measurement: Laboratory, arterial blood gas meter.;Paco2. Timepoint: Onse. Method of measurement: lab Test.;Hco3. Timepoint: Onse. Method of measurement: lab Test.;Buffer Base. Timepoint: Onse. Method of measurement: lab Test.;Base Exese. Timepoint: One day on the first day, the second day, the third day. Method of measurement: Laboratory, arterial blood gas meter.;PH. Timepoint: One day on the first day, the second day, the third day. Method of measurement: Laboratory, arterial blood gas meter. | — |
Secondary
| Measure | Time frame |
|---|---|
| Heparin 5000 unit. Timepoint: one day, second day,. Method of measurement: Laboratory, arterial blood gas meter. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactReza BORABADI
Sabzevar University of Medical Sciences, Sabzevar Towhid Town
Outcome results
None listed